[Should adjuvant or neoadjuvant treatment be administered in esophageal cancer?].
This paper is dedicated to adjuvant treatments in surgery for esophageal squamous cell carcinoma. Randomized studies of neo-adjuvant or adjuvant radiotherapy, chemotherapy or radio-chemotherapy are considered. No trial has yet demonstrated the efficacy of a treatment complementary to surgery. Clinical research must be persued, testing the most effective therapies in non-operable cancers of the esophagus, especially "up-to-date" radio-chemotherapy.
Bedenne
L
L
Service d'Hépato-Gastroentérologie, Hôpital du Bocage, Dijon.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002294:Carcinoma, Squamous Cell / Q000401:mortality / Q000601:surgery / Q000628:therapy*; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D004938:Esophageal Neoplasms / Q000401:mortality / Q000601:surgery / Q000628:therapy*; D005500:Follow-Up Studies; D006801:Humans; D011879:Radiotherapy Dosage; D018714:Radiotherapy, Adjuvant; D016019:Survival Analysis